Navigation Links
Data Conversion Laboratory Supports Newest SPL Requirements For Life Sciences Industry

FRESH MEADOWS, N.Y., Aug. 4 /PRNewswire/ -- Data Conversion Laboratory, Inc. (DCL), providing conversion services and software to publishers, information aggregators, industry, government, libraries and documentation developers, continues to be in the forefront supporting the life sciences community in complying with the FDA's SPL (Structured Product Labeling) initiative.

SPL is an XML standard used by the FDA community to facilitate communicating drug labeling data reliably among various medical groups. Since 2005, the FDA CDER division has mandated that all human prescription drugs be provided in SPL. Beginning in June, 2009 the FDA has required SPL filings for biologics, veterinary medicines and over-the-counter (OTC) products. Medical devices are expected to require SPL filing in 2010. Additionally, as a result of the Food and Drug Administration Amendments Act of 2007 mandating electronic submissions, SPL is now required for establishment registration, NDC labeler code requests and drug listing regulatory requirements.

As one of the world's leading providers of data conversion services, DCL has been well-positioned to understand the structure and usage of this new standard, and to assist affected organizations in implementing and utilizing SPL in a timely and efficient manner. DCL supports the full range of SPL filings, is up to date on all technical requirements and has implemented sophisticated multi-level quality assurance checks to validate SPL files prior to submission. To date, DCL has successfully completed more than 2,000 filings.

Mark Gross, DCL president, expanded on DCL's involvement with these regulations: "As a long-time member of the SPL Working Group helping to establish these standards, we were very comfortable with SPL from the beginning. As standards continue to evolve, our 28 years of industry experience and our ongoing interaction with the group enable us to provide rapid turnaround in support of our clients' labeling conversions with guaranteed conformance to FDA and EMEA standards."

About Data Conversion Laboratory, Inc.

Founded in 1981, DCL converts and organizes content to create electronic documents, populate databases and publish on the web, sustaining long-term strategic relationships with clients preparing for tomorrow's technology. DCL operates with facilities on four continents, providing support services for high-volume data-entry and data-processing using its real-time web-accessible process control software. DCL's services help refine conversion strategy, identify document redundancy, extract metadata and transform legacy and future documents to meet our clients' real needs - today and in the future. DCL converts from any format to any format, and has processed more than a quarter billion pages.

    Don Bridges, SPL Product Manager

SOURCE Data Conversion Laboratory, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blood Test Shows Statistically Significant Association With Alzheimers Disease (AD), May Predict Conversion of Mild Cognitive Impairment to AD
2. Leading University Hospital Completes System-Wide Conversion to Masimo SET(R) Pulse Oximetry
3. Patent Issued for UNIVAL(R) D3(TM) Data Conversion System
4. Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service
5. Kentucky Medical Services Foundation Completes Successful Charge Capture Technology Conversion
6. Triple-S Management Corporation Announces Conversion of Class A Shares and Commencement of Class B Stock Repurchase Program
7. NJHA: Public Deserves Full Disclosure of Horizon Conversion Plan
8. Bioniche Allows Conversion of Portion of Revolving Credit Facility
9. Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
10. MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling $4 Million
11. Smart Balance Announces Conversion of Convertible Preferred Stock
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology: